Abstract
Nineteen noninsulin-dependent diabetic patients [ten women, nine men, aged 36-80 years (mean +/- SE 56.8 +/- 2.7 years)] were randomized to receive either glyburide or glipizide for 16 weeks, in a double-blind crossover fashion. A 2-week washout period preceded each treatment period. The patients measured blood glucose concentrations 16 times weekly using Chemstrip-bG. The medication dosages were titrated to achieve fasting blood glucose concentrations of less than or equal to 6.2 mM and preprandial and postprandial concentrations of less than or equal to 9.0 mM, or to a total daily dose of 20 mg for glyburide and 40 mg for glipizide. Glyburide therapy resulted in a significant decline in fasting, preprandial, postprandial and bedtime blood glucose levels, while glipizide treatment led to a significant lowering of postprandial and bedtime blood glucose. Furthermore, fasting, preprandial and postprandial blood glucose concentrations were significantly lower during glyburide as compared to glipizide treatment phase. Glycosylated hemoglobin levels were decreased only with glyburide. Serum C-peptide and insulin concentrations were not altered over the entire study. The mean final daily dose of glyburide (15.4 +/- 1.6 mg) was marked...Continue Reading
References
Jan 1, 1979·Acta Medica Scandinavica·G Blohmé, J Waldenström
Jan 1, 1979·Current Medical Research and Opinion·C H Klaassen
Jun 1, 1975·The Journal of Clinical Investigation·D L HorwitzA H Rubenstein
Nov 1, 1987·Diabetes·L GroopR A DeFronzo
Nov 1, 1987·Diabetes Care·L GroopA Melander
Mar 1, 1988·Annals of Internal Medicine·D M NathanJ E Godine
Mar 1, 1988·Diabetes Care·D CoxW Clarke
Jan 1, 1986·The Diabetes Educator·C Freeman
Aug 23, 1985·The American Journal of Medicine·D R Owens
Sep 20, 1985·The American Journal of Medicine·J M Falko, K Osei
Jan 1, 1985·European Journal of Clinical Pharmacology·L GroopF Fyhrqvist
Sep 1, 1973·Diabetologia·I De LeeuwH Verhaegen
Feb 1, 1973·The Journal of Clinical Pharmacology and New Drugs·L M FuccellaG Valzelli
Nov 30, 1983·The American Journal of Medicine·G M Reaven
Nov 30, 1983·The American Journal of Medicine·A Melander, E Wåhlin-Boll
Feb 1, 1981·The American Journal of Medicine·T G Skillman, J M Feldman
May 1, 1981·Clinical Pharmacokinetics·L Balant
Sep 1, 1981·Drugs·J E Jackson, R Bressler
Oct 1, 1981·The Journal of Clinical Investigation·O G KoltermanJ M Olefsky
May 1, 1981·Diabetes Care·P KubilisE D Rosenbloom
Mar 1, 1980·Annals of Internal Medicine·G BodenO E Owen
Citations
Mar 1, 1993·Journal of Clinical Pharmacology·L A JaberA V Neale
Sep 1, 1995·Clinical Therapeutics·A V LawW H Arneson
Oct 6, 1997·Endocrinology and Metabolism Clinics of North America·B R Zimmerman
Jun 1, 2010·Acta Diabetologica·Kathryn M HurrenDavid L Ronis
Mar 1, 1992·Research in Veterinary Science·A B MillerE C Feldman
Oct 1, 1992·The Annals of Pharmacotherapy·M A NoyesR Ramirez